Dose, stability, absorption, and side effect monitoring are what make a therapy predictable, and those are exactly the elements most consumer patches lack
doi: 10.1016/j.cell.2021.01.010 69 ZhangLLiZSkrzypczynskaKMFangQZhangWOBrienSAet al
3,4 ADA Standards of Medical Care in Diabetes The 2017 ADA Standards of Medical Care in Diabetes offer the ADAs general recommendations for the use of antihyperglycemic therapy in T2DM
GLP-1
Os principais anlogos de GLP-1 incluem liraglutida (Victoza, Saxenda), semaglutida (Ozempic, Wegovy) e tirzepatida (Mounjaro)
And certainly we have data showing that those who are obese, diabetic, and have fatty liver have GLP 1 deficiency